Lincoln Pharma.

{
  "main_header": {
    "sid": 294056,
    "name": "Lincoln Pharma.",
    "stock_name": "Lincoln Pharma.",
    "full_name": "Lincoln Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/lincoln-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "538.00",
    "chg": 43.9,
    "chgp": "8.88%",
    "dir": 1,
    "prev_price": "494.10",
    "mcapval": "988.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531633,
    "symbol": "LINCOLN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE405C01035",
    "curr_date": "Feb 10",
    "curr_time": "",
    "bse_nse_vol": "92.67 k",
    "exc_status": "Active",
    "traded_date": "Feb 10, 2026",
    "traded_date_str": "2026 02 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lincoln-pharma-294056-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lincoln Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-sees-technical-momentum-shift-amid-mixed-market-signals-3829585",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LincolnPharmace_technicaldot_3829585.png",
        "date": "2026-02-10 08:01:34",
        "description": "Lincoln Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a cautious outlook for investors. While the stock has rebounded sharply in recent sessions, underlying monthly trends remain bearish, signalling a nuanced market sentiment in the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Why is Lincoln Pharmaceuticals Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lincoln-pharmaceuticals-ltd-fallingrising-3829298",
        "imagepath": "",
        "date": "2026-02-10 00:12:08",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Lincoln Pharmaceuticals’ sharp rise on 09-Feb stands out against its recent performance, where it had been on a downward trajectory for three sessions. The stock’s intraday high reached ₹496.7, reflecting a robust 7.93% increase from the previous close. This surge outpaced the broader sector by 5.76%, indicating that the stock is currently outperforming its pharmaceutical peers. Such relative strength often attracts momentum traders and signals potential for further gains.</p>\n<p>Examining the stock’s moving averages reveals that the current price is comfortably above its 5-day, 20-day, and 50-day averages, suggesting short- to medium-term bullishness. However, it remains below the longer-term 100-day and 200-day moving averages, indic..."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3817715",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/LincolnPharmace_mojoScore_3817715.png",
        "date": "2026-02-03 10:14:03",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs43995-3807601",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3807601.png",
        "date": "2026-01-28 10:41:39",
        "description": "Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs-44285-3806342",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3806342.png",
        "date": "2026-01-27 15:42:42",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lincoln-pharmaceuticals-ltd-is-rated-sell-3801384",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_mojoScore_3801384.png",
        "date": "2026-01-23 10:10:54",
        "description": "Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs45305-3798669",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3798669.png",
        "date": "2026-01-21 11:51:57",
        "description": "Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-stock-falls-to-52-week-low-of-rs45455-3796075",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3796075.png",
        "date": "2026-01-20 10:24:21",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns."
      },
      {
        "title": "Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lincoln-pharmaceuticals-ltd-falls-to-52-week-low-of-rs46525-3794456",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/LincolnPharmace_priceRelatedfactors_3794456.png",
        "date": "2026-01-19 10:32:18",
        "description": "Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns."
      }
    ],
    "total": 940,
    "sid": "294056",
    "stock_news_url": "https://www.marketsmojo.com/news/lincoln-pharmaceuticals-294056"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31St December 2025.",
      "datetime": "04-Feb-2026",
      "details": "Lincoln Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve unaudited Financial Results (Standalone And Consolidated) Of The Company For The Third Quarter And Nine Months Ended 31st December 2025 And Other Business if any.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
      "datetime": "10-Jan-2026",
      "details": "Update on Credit Rating.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Pursuant to provision of Regulation 74(5) of SEBI (Depository and Participants) Regulation 2018 we hereby submit the confirmation certificate received from MUFG Intime India Private Limited Registrar and Share Transfer Agent (RTA) for the Quarter ended December 31 2025.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has declared <strong>18%</strong> dividend, ex-date: 12 Sep 25",
          "dt": "2025-09-12",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lincoln Pharmaceuticals Ltd has announced <strong>10:2</strong> stock split, ex-date: 19 Mar 09",
          "dt": "2009-03-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lincoln Pharmaceuticals Ltd Sees Technical Momentum Shift Amid Mixed Market Signals

2026-02-10 08:01:34

Lincoln Pharmaceuticals Ltd has experienced a notable shift in price momentum, reflected in a complex interplay of technical indicators that suggest a cautious outlook for investors. While the stock has rebounded sharply in recent sessions, underlying monthly trends remain bearish, signalling a nuanced market sentiment in the Pharmaceuticals & Biotechnology sector.

Read full news article

Why is Lincoln Pharmaceuticals Ltd falling/rising?

2026-02-10 00:12:08

Recent Price Movement and Market Context

Lincoln Pharmaceuticals’ sharp rise on 09-Feb stands out against its recent performance, where it had been on a downward trajectory for three sessions. The stock’s intraday high reached ₹496.7, reflecting a robust 7.93% increase from the previous close. This surge outpaced the broader sector by 5.76%, indicating that the stock is currently outperforming its pharmaceutical peers. Such relative strength often attracts momentum traders and signals potential for further gains.

Examining the stock’s moving averages reveals that the current price is comfortably above its 5-day, 20-day, and 50-day averages, suggesting short- to medium-term bullishness. However, it remains below the longer-term 100-day and 200-day moving averages, indic...

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-02-03 10:14:03

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.439.95

2026-01-28 10:41:39

Lincoln Pharmaceuticals Ltd’s stock price declined to a fresh 52-week low of Rs.439.95 on 28 Jan 2026, marking a significant downturn amid broader market gains. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and valuation metrics.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs 442.85

2026-01-27 15:42:42

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.442.85 on 27 Jan 2026, marking a significant milestone in the stock’s recent performance. The pharmaceutical company’s stock has been under pressure, reflecting a combination of subdued financial results and broader sector dynamics.

Read full news article

Lincoln Pharmaceuticals Ltd is Rated Sell

2026-01-23 10:10:54

Lincoln Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.453.05

2026-01-21 11:51:57

Lincoln Pharmaceuticals Ltd has touched a fresh 52-week low of Rs.453.05 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its financial performance and market sentiment.

Read full news article

Lincoln Pharmaceuticals Ltd Stock Falls to 52-Week Low of Rs.454.55

2026-01-20 10:24:21

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.454.55 on 20 Jan 2026, marking a significant downturn amid broader market fluctuations and company-specific performance concerns.

Read full news article

Lincoln Pharmaceuticals Ltd Falls to 52-Week Low of Rs.465.25

2026-01-19 10:32:18

Lincoln Pharmaceuticals Ltd’s shares declined to a fresh 52-week low of Rs.465.25 on 19 Jan 2026, marking a significant downturn amid broader market weakness and company-specific performance concerns.

Read full news article

View All News